Stay updated on CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Sign up to get notified when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.

Latest updates to the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe revisions metadata now shows v3.3.2 instead of v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedThe government funding/operating status disclaimer was removed from the page.SummaryDifference0.3%

- Check36 days agoChange DetectedThe updates are administrative edits to the trial record, including the last update date, with no changes to core study information (design, endpoints, eligibility, or treatments). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedMajor update includes a government operating status notice and a new version tag (v3.2.0); removal of a specific resource (Carcinoma of esophagus) from genetic resources.SummaryDifference3%

- Check71 days agoChange DetectedUpgrade to revision v3.1.0 with added contact details (phone and email) corresponding to support or inquiry, replacing the previous v3.0.2.SummaryDifference0.1%

- Check86 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; Back to Top removed.SummaryDifference0.1%

Stay in the know with updates to CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 + FOLFOX/PD-1 +/- Trastuzumab Clinical Trial page.